About Polaris Genomics
Polaris Genomics is a company based in Rockville (United States) founded in 2017 by Tshaka Cunningham.. Polaris Genomics has raised $800 thousand across 8 funding rounds from investors including Illumina and Sanford Health. Polaris Genomics offers products and services including ADAPT Panel™ and PTS-ID™. Polaris Genomics operates in a competitive market with competitors including Assurex Health, PierianDx, Treos Bio, Circular Genomics and Ignyta, among others.
- Headquarter Rockville, United States
- Founders Tshaka Cunningham
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Trugenomix, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$800 K (USD)
in 8 rounds
-
Latest Funding Round
$250 K (USD), Debt – Conventional
Aug 19, 2025
-
Investors
Illumina
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Polaris Genomics
Polaris Genomics offers a comprehensive portfolio of products and services, including ADAPT Panel™ and PTS-ID™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Facilitates neuropsychiatric biomarker development using genomic data.
Enables objective mental health evaluations through biology-based methods.
Unlock access to complete
Unlock access to complete
Funding Insights of Polaris Genomics
Polaris Genomics has successfully raised a total of $800K across 8 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $250 thousand completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Debt – Conventional — $250,000
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2025 | Amount | Debt – Conventional - Polaris Genomics | Valuation |
investors |
|
| Oct, 2023 | Amount | Debt – Conventional - Polaris Genomics | Valuation |
investors |
|
| May, 2023 | Amount | Debt – Conventional - Polaris Genomics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Polaris Genomics
Polaris Genomics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Illumina and Sanford Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Operator of integrated healthcare system providing medical services and health plans
|
Founded Year | Domain | Location | |
|
Developer of technologies for analysis of genetic variation and function
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Polaris Genomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Polaris Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Polaris Genomics Comparisons
Competitors of Polaris Genomics
Polaris Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Assurex Health, PierianDx, Treos Bio, Circular Genomics and Ignyta, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Personalized medication for neuropsychiatric conditions is guided by pharmacogenomics.
|
|
| domain | founded_year | HQ Location |
Genetic tests for individualized disease diagnosis are provided.
|
|
| domain | founded_year | HQ Location |
Developer of cancer vaccines and companion diagnostics
|
|
| domain | founded_year | HQ Location |
RNA-based diagnostics and therapeutics for depression are developed and provided.
|
|
| domain | founded_year | HQ Location |
Personalized medicine is developed for cancer and autoimmune diseases.
|
|
| domain | founded_year | HQ Location |
Biological drug monitoring and molecular diagnostics are manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Polaris Genomics
When was Polaris Genomics founded?
Polaris Genomics was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is Polaris Genomics located?
Polaris Genomics is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.
Is Polaris Genomics a funded company?
Polaris Genomics is a funded company, having raised a total of $800K across 8 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $1M, raised on Apr 26, 2018.
What does Polaris Genomics do?
Founded in 2017 and based in Rockville, United States, Polaris Genomics operates in the biotechnology sector with a focus on neurological conditions. Genomic-based diagnostics and therapeutics are developed using the proprietary TruNorth Platform for neuropsychiatric genomic analysis. PTS-ID, a genomic test for diagnosing and treating post-traumatic stress disorder, is also advanced by the company.
Who are the top competitors of Polaris Genomics?
Polaris Genomics's top competitors include Assurex Health, Circular Genomics and PierianDx.
What products or services does Polaris Genomics offer?
Polaris Genomics offers ADAPT Panel™ and PTS-ID™.
Who are Polaris Genomics's investors?
Polaris Genomics has 2 investors. Key investors include Illumina, and Sanford Health.